The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

ARE TRANQUILIZER COMBINATIONS MORE EFFECTIVE THAN A SINGLE TRANQUILIZER?

Published Online:https://doi.org/10.1176/ajp.121.6.597

This study sought to assess the common practice of combination tranquilizer therapy in chronic psychotics. Conducted under double-blind conditions, it compared the efficacy and side effects from 3 regimens over a course of 8 months: 1. Chlorpromazine plus trifluoperazine; 2 Chlorpromazine plus trifluoperazine placebo; and 3. Trifluoperazine plus chlorpromazine placebo. It showed that with the two drugs combined efficacy was greater than with these drugs used individually. It showed, too, that with the drugs in combination side effects were about half what they were with trifluoperazine and not much more than they were with chlorpromazine (18% and 12% respectively). Therefore, from this study, it appears that the combination of chlorpromazine and trifluoperazine offers advantages in patients who do not respond to treatment with a single tranquilizer or who develop limiting side effects on high doses of a single tranquilizer.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.